Page last updated: 2024-11-04

sevoflurane and Ornithine Carbamoyltransferase Deficiency Disease

sevoflurane has been researched along with Ornithine Carbamoyltransferase Deficiency Disease in 1 studies

Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.

Ornithine Carbamoyltransferase Deficiency Disease: An inherited urea cycle disorder associated with deficiency of the enzyme ORNITHINE CARBAMOYLTRANSFERASE, transmitted as an X-linked trait and featuring elevations of amino acids and ammonia in the serum. Clinical features, which are more prominent in males, include seizures, behavioral alterations, episodic vomiting, lethargy, and coma. (Menkes, Textbook of Child Neurology, 5th ed, pp49-50)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sunder, RA1
Agarwal, A1

Other Studies

1 other study available for sevoflurane and Ornithine Carbamoyltransferase Deficiency Disease

ArticleYear
Anaesthetic management of a patient with ornithine transcarbamylase deficiency.
    Acta anaesthesiologica Scandinavica, 2006, Volume: 50, Issue:10

    Topics: Administration, Topical; Analgesics; Anesthesiology; Anesthetics, General; Fentanyl; Humans; Lens Di

2006